Shan-Mei Xu
- Molecular Biology top 10%
- Congenital heart defects research 9
- Ubiquitin and proteasome pathways 2
- Angiogenesis and VEGF in Cancer 2
- Genetics top 10%
-
- Cancer-related molecular mechanisms research 3
- Cell Biology top 10%
- Genetics top 10%
-
- Catalytic C–H Functionalization Methods 6
- Catalytic Cross-Coupling Reactions 4
- Catalytic Alkyne Reactions 3
- Synthesis and biological activity 2
- Co-authors
- Brian L. BlackEvdokia DodouPao‐Tien ChuangJoshua P. AndersonMichael P. VerziYajun LiTakatoshi KawakamiMiao-Hsueh Chen
- Partner nations
- United StatesChinaFrance
In The Last Decade
Shan-Mei Xu
28 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 1.2k
- Genetics 288
- Cancer Research 145
- Cell Biology 150
- Genetics 92
Countries citing papers authored by Shan-Mei Xu
This map shows the geographic impact of Shan-Mei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan-Mei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan-Mei Xu more than expected).
Fields of papers citing papers by Shan-Mei Xu
This network shows the impact of papers produced by Shan-Mei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan-Mei Xu. The network helps show where Shan-Mei Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shan-Mei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 10 | |
| 5 | 2022 | 12 | |
| 6 | 2020 | 33 | |
| 7 | 2015 | 11 | |
| 8 | 2015 | 21 | |
| 9 | 2015 | 39 | |
| 10 | 2014 | 39 | |
| 11 | 2014 | 24 | |
| 12 | 2012 | 87 | |
| 13 | 2011 | 47 | |
| 14 | 2011 | 40 | |
| 15 | 2010 | 37 | |
| 16 | 2010 | 133 | |
| 17 | 2009 | 46 | |
| 18 | 2004 | 287 | |
| 19 | 2004 | 67 | |
| 20 | 2003 | 117 |
About Shan-Mei Xu
Shan-Mei Xu is a scholar working on Cancer Research, Toxicology and Molecular Biology, having authored 30 papers that have together received 1.6k indexed citations. Recurring topics across this work include Congenital heart defects research (9 papers), Catalytic C–H Functionalization Methods (6 papers), Catalytic Cross-Coupling Reactions (4 papers), Cancer-related molecular mechanisms research (3 papers), Catalytic Alkyne Reactions (3 papers), Synthesis and biological activity (2 papers), Ubiquitin and proteasome pathways (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Genetics (288 citations) and Cancer Research (145 citations). Shan-Mei Xu has collaborated with scholars based in United States, China and France. Frequent co-authors include Brian L. Black, Evdokia Dodou, Pao‐Tien Chuang, Joshua P. Anderson, Michael P. Verzi, Yajun Li, Takatoshi Kawakami, Miao-Hsueh Chen, Anabel Rojas and Sarah De Val. Their work appears in journals such as Developmental Biology, Development, Organic Letters, The Journal of Organic Chemistry and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.